ClinicalTrials.gov
public full text
Public Domain
Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)#332842
- Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis#160193
- 42 U.S.C. § 300b-5 — Sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment#594907
- Bosentan Use in Patients With Diabetic Nephropathy#909606
- Bosentan Treatment of Digital Ulcers Related to Systemic Sclerosis#325200
Record · ID 283142
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive